UT-Southwestern Medical Center: Three Drugs Target Resistant Breast Cancers Driven by HER2 Mutations
November 15, 2023
November 15, 2023
DALLAS, Texas, Nov. 15 (TNSres) -- The University of Texas Southwestern Medical Center issued the following news release:
A targeted therapy using three different drugs significantly delayed progression and extended survival for breast cancer patients whose HER2 gene is mutated, a multicenter study co-led by researchers at UT Southwestern Medical Center shows. The findings, published in Annals of Oncology, suggest a new strategy for a difficult-to-treat form of breast cancer that ha . . .
A targeted therapy using three different drugs significantly delayed progression and extended survival for breast cancer patients whose HER2 gene is mutated, a multicenter study co-led by researchers at UT Southwestern Medical Center shows. The findings, published in Annals of Oncology, suggest a new strategy for a difficult-to-treat form of breast cancer that ha . . .